Cohesys

Canada | Human Resilience & Biotechnology

Team: 10-50 Funding: Private
Contact: 🌐 Website

A drillless solution for bone fracture fixation that is under investigational testing

NATO DIANA 2026 Cohort
✉ Open in Gmail 📩 Open in Outlook 💻 Desktop Email App
Technology DC Value Prop Market Analysis Target Buyers Conversation Playbook Partnership Map Emerging Applications One-Pager
Technology Deep Dive

What They Built

Cohesys is developing a drillless solution for bone fracture fixation. This innovative technology aims to provide a less invasive and potentially faster method for stabilizing broken bones.

How It Works

While specific technical details are not provided, the 'drillless' nature implies a novel approach to securing bone fragments without the need for traditional drilling. This could involve advanced adhesive materials, interlocking mechanisms, or external compression systems.

Key Differentiators

The primary differentiator is the 'drillless' approach, which can reduce surgical complexity, minimize tissue damage, and potentially lower the risk of infection. This offers a significant advantage over conventional methods that rely on screws and plates requiring drilling.

Technology Readiness

The technology is currently 'under investigational testing,' suggesting it is in the later stages of development and preclinical or early clinical trials. This typically corresponds to a Technology Readiness Level (TRL) of 6-7, demonstrating a system prototype in a relevant or operational environment.

Data Center Value Proposition

Why DC Operators Should Care

Defense organizations should care about Cohesys due to its potential to revolutionize battlefield trauma care and improve outcomes for military personnel. A drillless solution could enable faster, more efficient fracture fixation in austere environments, reducing surgical time and complications.

Use Cases

Key defense use cases include rapid stabilization of combat-related fractures in field hospitals or forward surgical teams. It could also be invaluable for disaster relief operations, special forces medics, and military medical facilities globally.

Integration Points

This technology could be integrated into existing military surgical kits, mobile medical units, and field hospitals. Its simplicity and drillless nature might reduce the need for specialized equipment, making it highly adaptable to various operational settings.

Cost / ROI Framing

The return on investment for defense could come from reduced surgical times, lower infection rates, and faster recovery for injured personnel. This translates to decreased long-term medical costs, quicker return to duty, and improved overall force readiness.

📈
Market Analysis

Total Addressable Market

The total addressable market includes the global orthopedic trauma fixation market, with a specific focus on military and emergency medical applications. This encompasses all scenarios where rapid and effective bone fracture treatment is critical.

Current Alternatives

Current alternatives include traditional bone plates, screws, intramedullary nails, and external fixators, all of which typically require drilling into the bone. These methods can be invasive and time-consuming, especially in challenging environments.

Competitive Landscape

Cohesys competes with established medical device companies like Stryker, DePuy Synthes (Johnson & Johnson), and Zimmer Biomet, which offer conventional orthopedic trauma solutions. Its drillless approach provides a unique competitive edge.

Growth Drivers

The market for advanced trauma care solutions, particularly those offering less invasive and faster recovery options, is growing. For defense, continuous innovation in combat casualty care drives demand for technologies like Cohesys's.

🎯
Target Buyers

Buyer Personas

Key buyer personas include military surgeons, combat medics, medical procurement officers within defense ministries, and R&D leads in military medical research agencies. These individuals prioritize efficacy, ease of use, and rapid deployment.

Target Companies

Potential buyers include the Canadian Department of National Defence, the US Department of Defense (DoD), NATO member state defense ministries, and military hospitals worldwide. Organizations focused on combat casualty care and medical logistics would be prime targets.

Relevant Sessions

Cohesys should target medical technology showcases at defense innovation conferences, military medical procurement briefings, and events organized by DIANA (Defence Innovation Accelerator for the North Atlantic). Demonstrations at military medical training centers would also be beneficial.

💬
Conversation Playbook

Opening Lines

How are you currently addressing complex bone fractures in austere or rapidly evolving operational environments? What are the biggest challenges you face with traditional fracture fixation methods for military personnel?

Key Questions to Ask

What is the typical recovery time for a soldier with a severe fracture using current methods, and how critical is reducing that timeframe? How important is minimizing surgical complexity and infection risk in your operational settings? Are you exploring novel, less invasive solutions for battlefield trauma that could enhance soldier survivability and recovery?

Objection Handling

Our current methods are proven and reliable, why change? The cost of adopting new technology is prohibitive for our budget. Training requirements for a new system might be too high for our personnel.

Follow-Up Email Template

We can provide data on how a drillless solution reduces operative time and potential complications, leading to faster recovery. Let's discuss a pilot program or demonstration to showcase the ease of use and benefits in a simulated military environment. We can also share insights into the long-term cost savings from reduced complications and improved soldier readiness.
🤝
Partnership Map

Complementary DIANA Companies

Cohesys has secured funding from the Defence Innovation Accelerator for the North Atlantic (DIANA), indicating a direct strategic partnership with NATO's innovation ecosystem. This positions Cohesys for accelerated development and potential adoption across NATO member states.

Industry Partners

While not explicitly mentioned, Cohesys's DIANA partnership aligns it with NATO's broader defense capabilities development (DCD) goals. Its technology could contribute to enhancing medical readiness and resilience across the alliance.

Cross-Sell Opportunities

Potential cross-sell partners include medical device distributors specializing in military and emergency medicine, trauma care providers, and rehabilitation centers for veterans. Collaborations with other defense tech companies focused on soldier health and performance could also be explored.

Emerging Applications

💡 Creative Application Angle

Imagine a future where battlefield surgeons can rapidly stabilize severe fractures without the need for complex drilling, significantly reducing operative time and infection risk. This innovation could transform combat casualty care, offering a lifeline to soldiers in critical moments and accelerating their path to recovery.

Why This Matters

This technology is profoundly valuable to defense as it directly addresses critical pain points in military trauma care: the need for rapid, effective, and less invasive treatment of fractures in challenging environments. It ultimately enhances soldier survivability, reduces long-term medical burdens, and improves quality of life post-injury.

Technical Insight

The 'drillless' aspect of Cohesys's technology implies a sophisticated advancement in material science or biomechanical engineering. It suggests the use of novel fixation mechanisms, possibly involving advanced adhesives, shape-memory alloys, or intricate interlocking designs that provide robust stability without compromising bone integrity through drilling.

Partnership Angle

As a DIANA-backed company, Cohesys is strategically positioned to forge deep partnerships with NATO member states' defense organizations. This collaboration can leverage DIANA's network for accelerated development, rigorous testing in relevant military environments, and eventual procurement across the alliance, ensuring widespread adoption of this critical medical innovation.

Elevator Pitch

Cohesys is pioneering a drillless bone fracture fixation technology, poised to revolutionize military trauma care by offering a faster, less invasive, and more resilient solution for combat injuries, backed by NATO's DIANA program.

More in Human Resilience & Biotechnology

AUXSYS Aboa Space Research Oy Avivo Biomedical Inc. Beyond Blood Diagnostics Biocellis Deep Breathe Inc. Elitac Wearables GutSee Health Herges Detection GmbH Hourglass Medical